VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2015 | Adaptive licensing: A new approach for authorizing medicines

At the 20th Congress of the European Hematology Association (EHA), Stephen O’Brien, BSc (Hons), PhD, MBChB, FRCP, FRCPath, of the University of Newcastle, Newcastle upon Tyne, UK, explains the process of adaptive licensing of new medicines, which aims to improve timely access for patients to new medicines.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter